Sesen Bio, Inc. (SESN) financial statements (2020 and earlier)

Company profile

Business Address 245 FIRST STREET
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments485015253654
Cash and cash equivalents485015253654
Other undisclosed current assets610100
Total current assets:545215263654
Noncurrent Assets
Property, plant and equipment001100
Intangible assets, net (including goodwill)59595977 0
Goodwill13131317  
Intangible assets, net (excluding goodwill)46464661 0
Restricted cash and investments000000
Other noncurrent assets0 0 00
Other undisclosed noncurrent assets     (0)
Total noncurrent assets:6060607811
TOTAL ASSETS:114112751043755
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities865335
Accounts payable211212
Accrued liabilities654222
Employee-related liabilities     1
Interest and dividends payable     0
Debt    40
Due to related parties   0  
Deferred revenue and credits 001
Other liabilities0     
Other undisclosed current liabilities     (1)
Total current liabilities:965485
Noncurrent Liabilities
Long-term debt and lease obligation    1010
Long-term debt, excluding current maturities    1010
Liabilities, other than long-term debt13349406103
Deferred compensation liability, classified     0
Deferred tax liabilities, net  16  
Deferred income tax liabilities13
Other liabilities 00 0 
Business combination, contingent consideration, liability120484045  
Derivative instruments and hedges, liabilities     3
Total noncurrent liabilities:1334940611013
Total liabilities:1415545651818
Stockholders' equity
Stockholders' equity attributable to parent(27)4418391937
Common stock000000
Additional paid in capital267230170162144129
Accumulated deficit(294)(186)(152)(123)(125)(92)
Total stockholders' equity:(27)4418391937
Other undisclosed liabilities and equity 131300 
TOTAL LIABILITIES AND EQUITY:114112751043755

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues  0002
Revenue, net0301 
Cost of revenue
(Cost of Goods and Services Sold)
     (0)
Gross profit:  0002
Operating expenses(108)(35)(30)(27)(36)(35)
Other undisclosed operating income   3010
Operating income (loss):(108)(35)(29)3(35)(33)
Nonoperating income (expense)110(1)2(1)
Other nonoperating income (expense)110(1)3(1)
Interest and debt expense   (0) (0)
Other undisclosed income from continuing operations before equity method investments, income taxes   0  
Income (loss) from continuing operations before income taxes:(108)(34)(29)2(33)(35)
Income tax expense   (0)  
Net income (loss):(108)(34)(29)2(33)(35)
Other undisclosed net income attributable to parent     0
Net income (loss) attributable to parent:(108)(34)(29)2(33)(34)
Preferred stock dividends and other adjustments     (1)
Net income (loss) available to common stockholders, diluted:(108)(34)(29)2(33)(35)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(108)(34)(29)2(33)(35)
Comprehensive income (loss), net of tax, attributable to parent:(108)(34)(29)2(33)(35)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: